Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.26 USD | -5.17% | -5.60% | -39.80% |
Apr. 17 | Wilsons Downgrades Avita Medical to Market-Weight From Overweight; Price Target is AU$3.03 | MT |
Apr. 11 | BTIG Research Downgrades Avita Medical to Neutral From Buy | MT |
Sales 2024 * | 115M 76.08M | Sales 2025 * | 164M 108M | Capitalization | 323M 213M |
---|---|---|---|---|---|
Net income 2024 * | -56M -36.94M | Net income 2025 * | -17M -11.22M | EV / Sales 2024 * | 2.63 x |
Net cash position 2024 * | 19.8M 13.06M | Net cash position 2025 * | 1.85M 1.22M | EV / Sales 2025 * | 1.96 x |
P/E ratio 2024 * |
-5.67
x | P/E ratio 2025 * |
-28.5
x | Employees | 207 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.3% |
Latest transcript on AVITA Medical, Inc.
1 day | -5.17% | ||
1 week | -5.60% | ||
Current month | -1.67% | ||
1 month | -20.19% | ||
3 months | -54.11% | ||
6 months | -26.84% | ||
Current year | -39.80% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.49% | 4 M€ | -5.15% | - | |
0.00% | 0 M€ | +3.63% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 8.26 | -5.17% | 329,508 |
24-05-09 | 8.71 | -2.79% | 368,469 |
24-05-08 | 8.96 | -4.38% | 371,776 |
24-05-07 | 9.37 | +5.28% | 171,445 |
24-05-06 | 8.9 | +1.71% | 131,256 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.80% | 213M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- RCEL Stock